2016
DOI: 10.1186/s13223-016-0153-x
|View full text |Cite
|
Sign up to set email alerts
|

Co-exposure to zymosan A and heat-inactivated Asian sand dust exacerbates ovalbumin-induced murine lung eosinophilia

Abstract: BackgroundEpidemiological studies have implicated Asian sand dust (ASD) in the increased prevalence of respiratory disorders, including asthma. It has been observed that fungal elements such as β-glucan can be adsorbed onto ASD. In the present study, the exacerbating effect of the combined exposure to zymosan A (ZymA) containing yeast β-glucan and heat-inactivated ASD on ovalbumin (OVA)-induced murine lung eosinophilia was investigated.MethodsBALB/c mice were repeatedly instilled intratracheally with one of ei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 53 publications
0
5
0
Order By: Relevance
“…Τhe exacerbating effect of a combined exposure to zymosan A (ZymA; from the yeast Saccharomyces cerevisiae , as a source of β-glucan) and H-ASD (National Institute for Environmental Study No.30 ‘Gobi Kosa Dust’) on OVA-induced murine lung eosinophilia has also been investigated ( Sadakane et al 2016 ). Male BALB/c mice were repeatedly instilled IT with one of eight immunogenic formulations prepared with mixed or individual solutions of (1) ZymA, (2) H-ASD (100 μg), and (3) OVA.…”
Section: Resultsmentioning
confidence: 99%
“…Τhe exacerbating effect of a combined exposure to zymosan A (ZymA; from the yeast Saccharomyces cerevisiae , as a source of β-glucan) and H-ASD (National Institute for Environmental Study No.30 ‘Gobi Kosa Dust’) on OVA-induced murine lung eosinophilia has also been investigated ( Sadakane et al 2016 ). Male BALB/c mice were repeatedly instilled IT with one of eight immunogenic formulations prepared with mixed or individual solutions of (1) ZymA, (2) H-ASD (100 μg), and (3) OVA.…”
Section: Resultsmentioning
confidence: 99%
“…We hypothesized that co-exposure of LPS and ZymA with H-ASD The co-exposure induced a significant increase in total cell number and production of MCP-1 and MCP-3 and tended to increase Kitaura et al, 1996;Ponath et al, 1996), and MCP-1 and IL-17 facilitate the recruitment of monocytes (Matsushima, Larsen, DuBois, & Oppenheim, 1989) and neutrophils (Laan et al, 1999), respectively, during inflammation. We used the same doses of LPS (1 ng) and ZymA (20 ng) as in previous studies (Ren et al, 2014;Sadakane et al, 2016). The levels of eotaxin, MCP-3 and MCP-1 in BALF were markedly increased in OVA + ZymA + H-ASD treatment compared with the control, ZymA only, OVA-only or OVA + ZymA treatment (IL-17 was not measured) (Sadakane et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…We used the same doses of LPS (1 ng) and ZymA (20 ng) as in previous studies (Ren et al, ; Sadakane et al, ). The levels of eotaxin, MCP‐3 and MCP‐1 in BALF were markedly increased in OVA + ZymA + H‐ASD treatment compared with the control, ZymA only, OVA‐only or OVA + ZymA treatment (IL‐17 was not measured) (Sadakane et al, ). For LPS, the OVA + LPS (1 ng) + H‐ASD treatment tended to increase these chemokines and IL‐17 compared with control, LPS‐only, OVA‐only or OVA + LPS treatment, but the effect was not significant (Ren et al, ).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations